Physician profile
Su Min Chang
NPI 1164499240
$10,969.28
in general payments reported to CMS, 2019-2025
22 companies · $1,233 in 2025
The $1,233 reported for 2025 was more than what 75% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $687 · 2020: $316 · 2021: $731 · 2022: $3,858 · 2023: $1,233 · 2024: $2,911 · 2025: $1,233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,817 · Travel and Lodging: $1,147 · Consulting Fee: $246 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,816.90 |
| Travel and Lodging | $1,147.45 |
| Consulting Fee | $246.42 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $165.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $2,898.22 | 2019-2025 | Ffrct |
| Siemens Medical Solutions USA, INC. | $2,434.32 | 2019-2025 | Naeotom Alpha, Somatom Force, Syngo Dynamics |
| Philips North America LLC | $753.77 | 2022 | |
| Edwards Lifesciences Corporation | $736.12 | 2021-2025 | The Edwards Sapien 3 Valve With Alterra Adaptive Prestent System, Sapien 3 Ultra Resilia |
| Medtronic, INC. | $693.35 | 2022-2023 | Corevalve Evolut R, Harmony |
| Abbott Laboratories | $666.05 | 2019-2025 | Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Bolton Medical INC | $573.55 | 2021-2022 | |
| Jenavalve Technology, INC. | $540.74 | 2024-2025 | |
| Cleerly, INC. | $469.14 | 2023-2025 | Cleerly Labs, Cleerly Ischemia |
| Amgen INC. | $349.14 | 2019-2024 | Repatha |
| Boston Scientific Corporation | $318.27 | 2022-2025 | Avvigo Guidance System, Farapulse |
| Pfizer INC. | $132.94 | 2019-2024 | |
| Medtronic Vascular, INC. | $109.61 | 2019 | |
| Ge Healthcare | $81.77 | 2019-2020 | |
| Astellas Pharma US INC | $56.76 | 2019-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $31.63 | 2021-2024 | Flexitouch Plus, Entre Plus |
| Kiniksa Pharmaceuticals, LTD. | $30.33 | 2022-2023 | Arcalyst |
| Novo Nordisk INC | $25.92 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $18.29 | 2023 | |
| Alnylam Pharmaceuticals INC. | $17.71 | 2019 | |
| Lantheus Medical Imaging, INC. | $17.17 | 2024 | |
| Janssen Pharmaceuticals, INC | $14.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Su Min Chang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.